Research News

Immune pathway upregulation and lower genomic instability distinguish EBVpositive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS

Primary Epstein-Barr virus (EBV)-positive nodal T/NK-cell lymphoma (PTCL-EBV) is an aggressive and poorly understood disease that occurs mostly in East Asia. In this collaborative study, led by A/Prof Ng Siok Bian and Dr Jason Pitt, the authors and their team characterise PTCL-EBV as an aggressive lymphoma with minimal genomic instability, immune-related gene expression and activation of NFκB along with its associated genes. These findings afford both novel insight into the pathogenesis of this disease and highlight new potential targets for therapeutic development.

Read more: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335103/

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

Extracellular Vesicles: Key Players in Tumour Microenvironment and Drug Resistance

This research, led by N2CR members Prof Goh Boon Cher and Prof Shazib Pervaiz with Dr Jayshree Hirpara as the …

Read More →
Research News

DriverDetect Software: Enhancing Cancer Mutation Prediction with Machine Learning

Detecting cancer-driving mutations is crucial for understanding cancer and developing treatments. Existing prediction tools vary in accuracy. N2CR member A/Prof …

Read More →
Research News

Understanding RNA Changes and Cancer Development

Led by N2CR member A/Prof Polly Chen, this research highlights the crucial role of ‘death associated protein 3’ (DAP3) in …

Read More →